ETERNAL YOUTH

Ambrosia's founder, Dr Jesse Karmazin, said: 'Its like plastic surgery from the inside out'

A US company is offering older patients teenage blood transfusions worth 6,200 ($8,000) so they can come pretty close to immortality.

Ambrosia, an American start-up, claims the procedures can reverse the effects of ageing.

Getty - Contributor

More than 100 adults around the age of 60 have tried the procedure since its launch in 2016, the Sunday Times reports.

Jesse Karmazin, 32, a doctor trained at Americas elite Stanford university, is pleased with the visible results.

Mr Karmazin, who founded Ambrosia, said: It could help improve things such as appearance or diabetes or heart function or memory.

These are all the aspects of ageing that have a common cause.

Im not really in the camp of saying this will provide immortality but I think it comes pretty close, essentially.

Ambrosia buys surplus blood from banks ideally from teenage donors and then separates the plasma from the cells.

E+ - Getty

Alamy

During the procedure, patients are injected with two and a half litres of blood mixed from several donors.

Criticising the treatment, Brit experts from UCL have blasted the procedure as a placebo.

Arne Akbar told the New Scientist, that the positive effects patients have felt could be down to the fact theyre paying so much money and hope to receive benefits from it rather than it actually producing substantial results.

Patients experience the placebo effect when they see an improvement in their symptoms after receiving fake or empty treatment.

David Gems, also from UCL, said more tests were necessary to determine the procedures effectiveness.

Ignoring their comments, Mr Karmazin said blood transfusions are a well-known procedure so more detailed tests are not necessary.

Getty - Contributor

Insisting the benefits are visible, Mr Karmazin said: Were already seeing people look better after just one treatment.

Its like plastic surgery from the inside out.

See the rest here:
Blood of teenagers being injected into OAPS for 6000 a shot by US company who claim it leaves the elderly 'pretty ... - The Sun